NEUPATH HEALTH INC (NPTH.CA) Stock Overview
Canada - TSX-V:NPTH - CA64133P1009 - Common Stock
NPTH.CA Key Statistics, Chart & Performance
The current stock price of NPTH.CA is 0.305 CAD. In the past month the price increased by 1.67%. In the past year, price increased by 90.63%.
NPTH.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.40B | ||
| AND.CA | ANDLAUER HEALTHCARE GROUP IN | 34.12 | 2.08B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 19.71 | 1.58B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.28B | ||
| AIDX.CA | HEALWELL AI INC | N/A | 381.31M | ||
| QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 156.93M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | N/A | 30.56M | ||
| ARC.CA | ARCPOINT INC | 1.17 | 4.49M | ||
| PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 1.94M |
Related stock screener links
About NPTH.CA
Company Profile
NeuPath Health, Inc. operates as a healthcare services company that provides chronic pain management services. The company is headquartered in Mississauga, Ontario and currently employs 148 full-time employees. The company went IPO on 2019-12-03. The company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical companies. The firm's health care providers cover a range of specialties and include physiatrists, neurologists, anesthesiologists, orthopedic surgeons, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, among others.
Company Info
NEUPATH HEALTH INC
110 - 110 Matheson Blvd West
Mississauga ONTARIO L5N 3E7 CA
CEO: Grant Connelly
Employees: 148
Phone: 18002653429
NEUPATH HEALTH INC / NPTH.CA FAQ
What is the stock price of NEUPATH HEALTH INC today?
The current stock price of NPTH.CA is 0.305 CAD. The price decreased by -1.61% in the last trading session.
What is the ticker symbol for NEUPATH HEALTH INC stock?
The exchange symbol of NEUPATH HEALTH INC is NPTH and it is listed on the TSX Venture Exchange exchange.
On which exchange is NPTH.CA stock listed?
NPTH.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for NEUPATH HEALTH INC stock?
5 analysts have analysed NPTH.CA and the average price target is 0.51 CAD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 0.305. Check the NEUPATH HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEUPATH HEALTH INC worth?
NEUPATH HEALTH INC (NPTH.CA) has a market capitalization of 17.19M CAD. This makes NPTH.CA a Nano Cap stock.
How many employees does NEUPATH HEALTH INC have?
NEUPATH HEALTH INC (NPTH.CA) currently has 148 employees.
What are the support and resistance levels for NEUPATH HEALTH INC (NPTH.CA) stock?
NEUPATH HEALTH INC (NPTH.CA) has a support level at 0.29. Check the full technical report for a detailed analysis of NPTH.CA support and resistance levels.
Is NEUPATH HEALTH INC (NPTH.CA) expected to grow?
The Revenue of NEUPATH HEALTH INC (NPTH.CA) is expected to grow by 14.59% in the next year. Check the estimates tab for more information on the NPTH.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEUPATH HEALTH INC (NPTH.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NPTH.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NPTH.CA, evaluating the profitability, health, valuation and growth aspects
- NEUPATH HEALTH INC (NPTH.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUPATH HEALTH INC (NPTH.CA) Sales and EPS estimates to see what analysts future expectations are.
- NEUPATH HEALTH INC (NPTH.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUPATH HEALTH INC (NPTH.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUPATH HEALTH INC (NPTH.CA) Stock Chart to make your own analysis
- NEUPATH HEALTH INC (NPTH.CA) Latest news and press-releases to stay up to date.
Does NEUPATH HEALTH INC (NPTH.CA) stock pay dividends?
NPTH.CA does not pay a dividend.
When does NEUPATH HEALTH INC (NPTH.CA) report earnings?
NEUPATH HEALTH INC (NPTH.CA) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of NEUPATH HEALTH INC (NPTH.CA)?
NEUPATH HEALTH INC (NPTH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
NPTH.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NPTH.CA. When comparing the yearly performance of all stocks, NPTH.CA is one of the better performing stocks in the market, outperforming 84.67% of all stocks.
NPTH.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA. The financial health of NPTH.CA is average, but there are quite some concerns on its profitability.
NPTH.CA Financial Highlights
Over the last trailing twelve months NPTH.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -928.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.83% | ||
| ROE | -3.75% | ||
| Debt/Equity | 0.5 |
NPTH.CA Forecast & Estimates
5 analysts have analysed NPTH.CA and the average price target is 0.51 CAD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 0.305.
For the next year, analysts expect an EPS growth of 178.29% and a revenue growth 14.59% for NPTH.CA